Brought to you by 
Amgen pays $215mm for Bergamo to establish a presence in Brazil
03 May 2011
Executive Summary
In an effort to establish a presence in Brazil, Amgen Inc. has paid $215mm in cash for Bergamo, which supplies medications to hospitals, with an emphasis on oncology.
Deal Industry
- Pharmaceuticals
Deal Status
- Final
Deal Type
-
Acquisition
- Full Acquisition
- Payment Includes Cash
Already a Biomedtracker subscriber?
You have access to the full deal record through your subscription
Want to become a subscriber?
Subscribers get more deal details, updates, deal financials and deal products.
Questions?
Questions?
Please contact Sales at: (212) 520-2765 or email PharmaNewsSales@informa.com
Related Companies
You must sign in to use this functionality
Authentication.SignIn.HeadSignInHeader
Amgen pays $215mm for Bergamo to establish a presence in Brazil
Email Deal
All set! This article has been sent to my@email.address.
All fields are required. For multiple recipients, separate email addresses with a semicolon.
DCD.EmailPopout.Notice